Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The roles of salusins in atherosclerosis and related cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M.

J Am Soc Hypertens. 2011 Sep-Oct;5(5):359-65. doi: 10.1016/j.jash.2011.06.003. Review.

PMID:
21925457
2.

Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.

Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A.

Circulation. 2008 Feb 5;117(5):638-48. doi: 10.1161/CIRCULATIONAHA.107.712539. Epub 2008 Jan 22.

3.

Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T.

Int J Hypertens. 2013;2013:965140. doi: 10.1155/2013/965140. Epub 2013 Oct 22. Review.

4.

Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.

Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T.

Atherosclerosis. 2010 Sep;212(1):70-7. doi: 10.1016/j.atherosclerosis.2010.04.027. Epub 2010 May 4.

PMID:
20684826
5.

Biosynthesis and secretion of salusin-alpha from human cells.

Sato K, Koyama T, Shichiri M.

Peptides. 2008 Dec;29(12):2203-7. doi: 10.1016/j.peptides.2008.08.015. Epub 2008 Aug 28.

PMID:
18804130
6.

Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway.

Sun HJ, Zhao MX, Liu TY, Ren XS, Chen Q, Li YH, Kang YM, Zhu GQ.

Sci Rep. 2016 Mar 23;6:23596. doi: 10.1038/srep23596.

7.

Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.

Shiraishi Y, Watanabe T, Suguro T, Nagashima M, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M.

J Hypertens. 2008 Oct;26(10):1955-65. doi: 10.1097/HJH.0b013e32830b61d8.

PMID:
18806619
8.

Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

Watanabe T, Arita S, Shiraishi Y, Suguro T, Sakai T, Hongo S, Miyazaki A.

Curr Med Chem. 2009;16(5):550-63. Review.

PMID:
19199921
9.

Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Noguchi Y, Fujimoto K, Koyama T, Shichiri M.

Curr Protein Pept Sci. 2013 Sep;14(6):472-80. Review.

PMID:
23968353
10.

Release of salusin-beta from human monocytes/macrophages.

Sato K, Fujimoto K, Koyama T, Shichiri M.

Regul Pept. 2010 Jun 8;162(1-3):68-72. doi: 10.1016/j.regpep.2010.02.010. Epub 2010 Feb 20.

PMID:
20176058
11.

[Salusins and its cardiovascular effects].

Ren AJ, Lin L, Yan XH, Yuan WJ.

Sheng Li Ke Xue Jin Zhan. 2013 Jun;44(3):164-8. Review. Chinese.

PMID:
24027821
12.

Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice.

Zhou CH, Liu LL, Wu YQ, Song Z, Xing SH.

Can J Physiol Pharmacol. 2012 Apr;90(4):463-71. doi: 10.1139/Y2012-022.

PMID:
22462492
13.

Serum salusin-alpha level in rheumatoid arthritis.

Ozgen M, Koca SS, Dagli N, Balin M, Ustundag B, Isik A.

Regul Pept. 2011 Feb 25;167(1):125-8. doi: 10.1016/j.regpep.2010.12.003. Epub 2010 Dec 24.

PMID:
21185876
14.

TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression.

Yin YW, Liao SQ, Zhang MJ, Liu Y, Li BH, Zhou Y, Chen L, Gao CY, Li JC, Zhang LL.

Cell Death Dis. 2014 Dec 18;5:e1574. doi: 10.1038/cddis.2014.535. Erratum in: Cell Death Dis. 2015;6:1659.

15.

Salusins promote cardiomyocyte growth but does not affect cardiac function in rats.

Yu F, Zhao J, Yang J, Gen B, Wang S, Feng X, Tang C, Chang L.

Regul Pept. 2004 Nov 15;122(3):191-7.

PMID:
15491791
16.

Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78.

Xiao-Hong Y, Li L, Yan-Xia P, Hong L, Wei-Fang R, Yan L, An-Jing R, Chao-Shu T, Wen-Jun Y.

J Cardiovasc Pharmacol. 2006 Aug;48(2):41-6.

PMID:
16954820
17.

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease.

Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, Hirano T.

Sensors (Basel). 2012;12(4):4974-85. doi: 10.3390/s120404974. Epub 2012 Apr 18. Review.

18.

Expression of prosalusin in human neuroblastoma cells.

Nakayama C, Shichiri M, Sato K, Hirata Y.

Peptides. 2009 Jul;30(7):1362-7. doi: 10.1016/j.peptides.2009.03.021. Epub 2009 Apr 9.

PMID:
19540434
19.

Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.

Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, Adachi M, Shichiri M, Miyazaki A.

Hypertens Res. 2008 Mar;31(3):463-8. doi: 10.1291/hypres.31.463.

PMID:
18497465
20.

Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.

Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R, Iso Y, Koba S, Kobayashi Y, Koyama T, Shichiri M.

PLoS One. 2013 Oct 3;8(10):e76714. doi: 10.1371/journal.pone.0076714. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi: 10.1371/annotation/f628c1d6-4bee-4725-b434-690f169a7849.

Supplemental Content

Support Center